Sign Up Now to Download a Free Research Report on APRI
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Apricus Biosciences Inc.
Apricus Biosciences shares declined 19.7 percent on volume of 5.3 million shares traded to close at $2.65. The company announced the pricing of a public offering of 6 million shares of common stock at a price to the public of $2.85 per share. Shares of Apricus Biosciences have gained roughly 33 percent year-to-date.
Going forward ... (see research report)









